GENE ONLINE|News &
Opinion
Blog

Manufacturing
Government Agencies Spring into Action After Biomanufacturing Executive Order
2022-09-14
WuXi Biologics Adds Microbial Fermentation to CDMO Offering in Hangzhou
2022-07-05
Spying Rapid Growth, Avantor Invests in Manufacturing Hub in Singapore
2022-05-05
Bayer Focuses on Strengthening its Global Pharmaceuticals Production Network
2022-04-08
How Did the Russia Invasion of Ukraine Affect Global Biopharma?
2022-03-16
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
Psychedelics Player Goes Public via SPAC
2022-01-25
South Korea’s SK Inc., Develops Its CDMO Capabilities via Investment in the Center for Breakthrough Medicines
2022-01-21
China’s Innoforce Bags $157 Million to Boost Cell, Gene and RNA CDMO Services
2021-12-10
Coherent Biopharma, WuXi STA Collab Takes a Crack at Peptide-Drug Conjugates
2021-12-06
10x Genomics Eyes Regional Opportunities in Asia-Pacific, Launches First Overseas Manufacturing Hub
2021-10-26
Canada Signs Deal with Moderna to Build Vaccine Plant in the Country
2021-08-12
Japan’s Kyowa Inks Deal with Taiwan’s CDMO Firm to Manufacture Generic Drugs
2021-08-06
China’s BeiGene to Build a Biologics Manufacturing Site in the US
2021-08-04
Resilience Acquires Bluebird Bio’s Manufacturing Facility to Develop Next Gen Cell Therapies
2021-07-31
1 2 3 4
LATEST
AstraZeneca Welcomes Neurofibromatosis And Asthma Treatment Approvals in Japan
2022-09-28
Biogen Concludes $900 Million Settlement Before Posting Positive Data From Alzheimer’s Trial
2022-09-28
Arsenal Biosciences Announced Another $70 million Collaboration, This Time With Genentech
2022-09-27
Sciwind Biosciences And SynerK Join Forces To Develop siRNA Therapeutics
2022-09-27
Acticor Enrolls First Patient in Phase 2/3 Stroke Treatment Study
2022-09-27
Daiichi Sankyo Wins Approval For Cancer Treatment in Japan
2022-09-26
Seagen Strikes Potential $650 million Deal with LAVA Therapeutics for Cancer Treatment
2022-09-26
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!